Nausea, vomiting, diarrhea, constipation, and abdominal discomfort typically peak within the first few days after injection and often diminish with continued use as the body adapts to the medication's effects on gastric motility
Constipation is another driver
Stopping the medication suddenly can lead to a return of lost weight or an increase in blood sugar levels
This guide walks through every step of proper GHK-Cu reconstitution, from equipment selection through storage protocols
[1] It represents a novel class of medication as the first dual incretin receptor agonist, activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
President, Lilly Cardiometabolic Health and President, Lilly USA, said Lilly plans to planning to bolster its marketing of Mounjaro and launch efforts to boost demand for Zepbound, including a direct-to-consumer marketing campaign, in earnest in mid-November